We are live on ! Find out more
Handelsbanken Fonder

Handelsbanken Fonder Portfolio holdings

AUM $35.1B
1-Year Est. Return 47.76%
This Fund
S&P 500
This Quarter Est. Return
-4.07%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$17.9B
AUM Growth
-$793M
Cap. Flow
+$267M
Cap. Flow %
1.49%
Top 10 Hldgs %
26.07%
Holding
1,596
New
28
Increased
508
Reduced
192
Closed
32

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$68.4M
2
MDT icon
Medtronic
MDT
+$42M
3
MSFT icon
Microsoft
MSFT
+$36.1M
4
NVDA icon
NVIDIA
NVDA
+$31.7M
5
CNM icon
Core & Main
CNM
+$29.3M

Top Sells

Rank Stock Value
1
KEYS icon
Keysight
KEYS
+$57.4M
2
SEDG icon
SolarEdge
SEDG
+$54M
3
SBUX icon
Starbucks
SBUX
+$42.3M
4
LLY icon
Eli Lilly
LLY
+$38M
5
WMS icon
Advanced Drainage Systems
WMS
+$30.5M

Sector Composition

Rank Sector Weight
1 Technology 29.93%
2 Healthcare 21.64%
3 Industrials 10.25%
4 Financials 9.34%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECHO
1501
EchoStar
ECHO
$26.9B
$171K ﹤0.01%
10,216
VKTX icon
1502
Viking Therapeutics
VKTX
$3.97B
$170K ﹤0.01%
15,400
HIMS icon
1503
Hims & Hers Health
HIMS
$6.99B
$169K ﹤0.01%
26,800
GDS icon
1504
GDS Holdings
GDS
$6.56B
$159K ﹤0.01%
14,500
GOGO icon
1505
Gogo Inc
GOGO
$383M
$157K ﹤0.01%
13,200
LUMN icon
1506
Lumen
LUMN
$6.49B
$157K ﹤0.01%
110,700
CDE icon
1507
Coeur Mining
CDE
$19.3B
$155K ﹤0.01%
70,029
ETWO
1508
DELISTED
E2open Parent Holdings
ETWO
$155K ﹤0.01%
34,200
RVNC
1509
DELISTED
Revance Therapeutics, Inc.
RVNC
$155K ﹤0.01%
13,500
DRVN icon
1510
Driven Brands
DRVN
$2.05B
$154K ﹤0.01%
12,200
PACW
1511
DELISTED
PacWest Bancorp
PACW
$154K ﹤0.01%
19,511
PDM
1512
Piedmont Realty Trust
PDM
$1.19B
$150K ﹤0.01%
26,618
VISN
1513
Vistance Networks Inc
VISN
$2.67B
$148K ﹤0.01%
43,900
KYMR icon
1514
Kymera Therapeutics
KYMR
$9.48B
$147K ﹤0.01%
10,600
LZ icon
1515
LegalZoom.com
LZ
$930M
$147K ﹤0.01%
13,400
HLIT icon
1516
Harmonic Inc
HLIT
$1.3B
$146K ﹤0.01%
15,200
LESL icon
1517
Leslie's
LESL
$12.4M
$145K ﹤0.01%
1,280
TVTX icon
1518
Travere Therapeutics
TVTX
$5.86B
$145K ﹤0.01%
16,200
CMTG icon
1519
Claros Mortgage Trust
CMTG
$262M
$144K ﹤0.01%
13,000
RC
1520
Ready Capital
RC
$289M
$141K ﹤0.01%
+13,930
New +$153K
JELD icon
1521
JELD-WEN Holding
JELD
$164M
$140K ﹤0.01%
10,500
OPK icon
1522
Opko Health
OPK
$1.04B
$138K ﹤0.01%
86,121
FIGS icon
1523
FIGS
FIGS
$2.4B
$136K ﹤0.01%
23,100
CFFN icon
1524
Capitol Federal Financial
CFFN
$1.1B
$133K ﹤0.01%
27,948
IOVA icon
1525
Iovance Biotherapeutics
IOVA
$3.05B
$133K ﹤0.01%
29,200

Similar funds

Handelsbanken Fonder's Q3 2023 Portfolio in Review

As of Q3 2023, Handelsbanken Fonder held 1,596 positions worth $17.9B, down 4.3% from $18.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.8%. Handelsbanken Fonder opened 28 new positions and exited 32, leaving the 1,596-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.

  • Handelsbanken Fonder's largest Q3 2023 buy was TKO Group: 8,037 shares worth $676K.
  • Handelsbanken Fonder added most to Linde in Q3 2023, an estimated $68.4M increase.
  • Handelsbanken Fonder's biggest Q3 2023 reduction was Keysight, cutting an estimated $57.4M.
  • Handelsbanken Fonder fully exited Starbucks in Q3 2023, selling an estimated $42.3M.
  • Handelsbanken Fonder's ten largest holdings make up 26% of its $17.9B portfolio in Q3 2023.
  • Handelsbanken Fonder opened 28 new positions and closed 32 in Q3 2023.
  • Handelsbanken Fonder's portfolio value fell 4.3% quarter-over-quarter to $17.9B.

Based on Handelsbanken Fonder's 13F filing for Q3 2023, filed 19 Oct 2023.